Drug intelligence / Profile preview

Cannamedical Hybrid Forte

Development stage
Unknown
Lead developer
Cannamedical Pharma
Modality
Small Molecules
Administration
Inhalation, Oral
01

Overview

Cannamedical Hybrid Forte is a branded line of **medical cannabis flower** products marketed by Cannamedical Pharma for pharmacy dispensing in Germany. It consists of dried whole *Cannabis sativa* L. inflorescences from hybrid cultivars with relatively high tetrahydrocannabinol content, generally around 21% to 25%, and low cannabidiol content, typically below 1%. As a botanical natural-product drug, its pharmacology is driven primarily by phytocannabinoids, especially THC, which acts mainly as a partial agonist at cannabinoid receptors in the endocannabinoid system, with downstream effects on nociception, mood, appetite, sleep, and spasticity-related pathways. The product line includes distinct strain-specific presentations such as MAC 1, Gorilla Zkittlez, Blunicorn, Ghost Train Haze, and Critical Bilbo, sourced from multiple countries and supplied for physician-directed medical use in indications such as chronic pain and other symptom-driven conditions where medical cannabis is prescribed.

Brand names
Cannamedical Hybrid Forte
Other names
Cannabis flos
02

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on Cannamedical Hybrid Forte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cannamedical Hybrid Forte.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call